From owner-doc-jp@jp.FreeBSD.org Fri Aug 15 00:02:30 2008
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id m7EF2UL37975;
	Fri, 15 Aug 2008 00:02:30 +0900 (JST)
	(envelope-from owner-doc-jp@jp.FreeBSD.org)
Received: from vpn1.fr.macopharma.com (vpn1.fr.macopharma.com [194.250.104.57])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id m7EF2SJ37841
	for <doc-jp@jp.freebsd.org>; Fri, 15 Aug 2008 00:02:29 +0900 (JST)
	(envelope-from smex_e2k7@macopharma.com)
Received: from srvfr2k3011.gmp.local (100.10.2.11) by srvfr2k3010.gmp.local
 (100.10.2.10) with Microsoft SMTP Server (TLS) id 8.1.291.1; Thu, 14 Aug 2008
 08:01:21 +0200
Received: from Pickup by srvfr2k3013.gmp.local with Microsoft SMTP Server id
 8.1.291.1; Thu, 14 Aug 2008 06:01:21 +0000
X-Receiver: doc-jp@jp.freebsd.org
X-Sender: smex_e2k7@macopharma.com
thread-index: Acj90ysLd4efaLYRQFCDRLoAY0PlUg==
Thread-Topic: [MailServer Notification]Content Filtering Notification
From: Administrator <smex_e2k7@macopharma.com>
To: <doc-jp@jp.FreeBSD.org>
Message-ID: <1827260818164CA3807E414AB625288D@gmp.local>
MIME-Version: 1.0
Content-Type: text/plain; charset="utf-8"
Content-Transfer-Encoding: quoted-printable
X-Mailer: Microsoft CDO for Windows 2000
Content-Class: urn:content-classes:message
Importance: normal
Priority: normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.3790.4325
Reply-To: doc-jp@jp.FreeBSD.org
Precedence: list
Date: Thu, 14 Aug 2008 08:01:18 +0200
X-Sequence: doc-jp 59028
Subject: [doc-jp 59028] [MailServer Notification]Content Filtering Notification
Sender: owner-doc-jp@jp.FreeBSD.org
X-Originator: smex_e2k7@macopharma.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

This email has violated the Perso MACO.
and Quarantine entire message has been taken on 8/14/2008 8:00:25 AM.
Message details:
Server: SRVFR2K3011
Sender: doc-jp@jp.freebsd.org;
Recipient: fields@macopharma.com;
Subject: subject :)

Ce message et toutes les pi=C3=A8ces jointes (ci-apr=C3=A8s le "Message") s=
ont confidentiels et =C3=A9tablis =C3=A0 l'intention exclusive de ses desti=
nataires. Toute modification, =C3=A9dition, utilisation ou diffusion non au=
toris=C3=A9e est interdite. Si vous avez re=C3=A7u ce Message par erreur, m=
erci de le d=C3=A9truire et de nous en avertir imm=C3=A9diatement. L=E2=80=
=99ensemble =C3=A9conomique MACO PHARMA d=C3=A9cline toute responsabilit=C3=
=A9 au titre de ce Message s'il a =C3=A9t=C3=A9 alt=C3=A9r=C3=A9, d=C3=A9fo=
rm=C3=A9, falsifi=C3=A9 ou encore =C3=A9dit=C3=A9, diffus=C3=A9 ou utilis=
=C3=A9 sans autorisation.

This message and any attachments (the "Message") are confidential and inten=
ded solely for the addressees. Any unauthorized modification, edition, use =
or dissemination is prohibited. If you have received this Message by mistak=
e, please delete it and notify us immediately. MACO PHARMA Group shall not =
be liable for the Message if altered, changed, falsified, edited, diffused =
or used without authorization.
